Logo image
IRO Home Research units Researcher Profiles
Sign in
Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases
Journal article

Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases

Carla M Nester and Patrick D Brophy
Current opinion in pediatrics, Vol.25(2), pp.225-231
04/2013
DOI: 10.1097/MOP.0b013e32835df4a3
PMID: 23486421

View Online

Abstract

Antibodies, Monoclonal, Humanized - therapeutic use Graft Rejection - prevention & control Humans Glomerulonephritis - immunology Kidney Transplantation Complement Activation - immunology Hemolytic-Uremic Syndrome - immunology Complement C3 - immunology Glomerulonephritis - drug therapy Hemolytic-Uremic Syndrome - surgery Complement Inactivating Agents - therapeutic use Atypical Hemolytic Uremic Syndrome Hemolytic-Uremic Syndrome - drug therapy

Details

Logo image